Canada Pension Plan Investment Board’s Rhythm Pharmaceuticals RYTM Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,000	Closed	-$3.74M	–	2013
2025 Q3	$3.74M	Buy	+37,000	New	+$3.44M	﹤0.01%	801
2024 Q4	–	Sell	-67,000	Closed	-$3.51M	–	1495
2024 Q3	$3.51M	Sell	67,000 -350,000	-84%	-$16.8M	﹤0.01%	775
2024 Q2	$17.1M	Sell	417,000 -160,000	-28%	-$6.39M	0.02%	464
2024 Q1	$25M	Buy	577,000 +310,000	+116%	+$13.6M	0.03%	412
2023 Q4	$12.3M	Buy	+267,000	New	+$8.42M	0.02%	485

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Pension Plan Investment Board's RYTM Position: Q4 2025 in Review

Canada Pension Plan Investment Board sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2025, closing a stake of 37,000 shares — an estimated $3.74M sold.

Canada Pension Plan Investment Board first reported a position in RYTM in Q4 2023 and held it in 5 quarters. The position peaked at $25M in Q1 2024. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

Canada Pension Plan Investment Board reported no remaining Rhythm Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Canada Pension Plan Investment Board sold 37,000 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $3.74M.
Canada Pension Plan Investment Board first reported a position in Rhythm Pharmaceuticals in Q4 2023 and held it in 5 quarters.
Canada Pension Plan Investment Board's Rhythm Pharmaceuticals position peaked at $25M in Q1 2024.
279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2025, filed 17 Feb 2026.